Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 7
Submit an article Journal homepage
198
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluations

The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes

Ramon V Tiu Cleveland Clinic Taussig Cancer Center, Department of Hematologic Oncology and Blood Disorders, 9500 Euclid Avenue R35, Cleveland, Ohio 44195, USA +1 216 445 9353; +1 216 636 0636; [email protected]
, MD &
Mikkael A Sekeres Cleveland Clinic Taussig Cancer Center, Department of Hematologic Oncology and Blood Disorders, 9500 Euclid Avenue R35, Cleveland, Ohio 44195, USA +1 216 445 9353; +1 216 636 0636; [email protected]
, MD MS
Pages 1021-1030 | Published online: 12 Jun 2008

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

R Ria, M Moschetta, A Reale, G Mangialardi, A Castrovilli, A Vacca & F Dammacco. (2009) Managing myelodysplastic symptoms in elderly patients. Clinical Interventions in Aging 4, pages 413-423.
Read now

Articles from other publishers (14)

Anca Prica, Michelle Sholzberg & Rena Buckstein. (2014) Safety and efficacy of thrombopoietin-receptor agonists in myelodysplastic syndromes: a systematic review and meta-analysis of randomized controlled trials. British Journal of Haematology 167:5, pages 626-638.
Crossref
Anna Tarasova, David N. Haylock, Laurence Meagher, Cheang Ly Be, Jacinta White, Susan K. Nilsson, Jessica Andrade, Kellie Cartledge & David A. Winkler. (2013) Potent Agonists of a Hematopoietic Stem Cell Cytokine Receptor, c‐Mpl. ChemMedChem 8:5, pages 763-771.
Crossref
Rashmi Kanagal-Shamanna, Carlos E. Bueso-Ramos, Su S. Chen, Lynne V. Abruzzo, Marcos J. de Lima, Rachel L. Sargent, L. Jeffrey Medeiros & Gary Lu. (2011) Donor-derived isolated del(20q) after hematopoietic stem cell transplantation: report of two cases and review of the literature. Journal of Hematopathology 6:1, pages 25-32.
Crossref
Valeria Santini. (2012) Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins. Seminars in Hematology 49:4, pages 295-303.
Crossref
Jalal A. Jazayeri & Graeme J. Carroll. 2012. Therapeutic Proteins. Therapeutic Proteins 157 188 .
Suminda Hapuarachchi, Szilan Fodor, Izydor Apostol & Gang Huang. (2011) Use of capillary electrophoresis?sodium dodecyl sulfate to monitor disulfide scrambled forms of an Fc fusion protein during purification process. Analytical Biochemistry 414:2, pages 187-195.
Crossref
Kenneth H. Shain, Alan F. List & Rami S. Komrokji. 2011. Advances in Malignant Hematology. Advances in Malignant Hematology 153 171 .
Jessica Andrade, Teresa Cablewski, Glenn Condie, David Haylock, Laurence Meagher, Andrew Riches, Anna Tarasova, Jerome Werkmeister, Jacinta White & David Winkler. (2010) Zinc Is Not Required for Activity of TPO Agonists Acting at the c-Mpl Receptor Transmembrane Domain. ACS Chemical Biology 5:8, pages 741-745.
Crossref
Lisa Pleyer, Daniel Neureiter, Victoria Faber & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes 153 222 .
D Pulanic, J N Lozier & S Z Pavletic. (2009) Thrombocytopenia and hemostatic disorders in chronic graft versus host disease. Bone Marrow Transplantation 44:7, pages 393-403.
Crossref
Robert J. Cersosimo. (2009) Romiplostim in chronic immune thrombocytopenic purpura. Clinical Therapeutics 31:9, pages 1887-1907.
Crossref
Alan T Nurden, Jean-François Viallard & Paquita Nurden. (2009) New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. The Lancet 373:9674, pages 1562-1569.
Crossref
Jaclyn S. KingJoseph B. FarlandJ. Aubrey Waddell & Dominic A. SolimandoJrJr. (2009) Eltrombopag; Romiplostim. Hospital Pharmacy 44:3, pages 228-231.
Crossref
Raphael Itzykson & Pierre Fenaux. (2009) Optimal sequencing of treatments for patients with myelodysplastic syndromes. Current Opinion in Hematology 16:2, pages 77-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.